Skip to main content
SpringerLink
Log in

Cerebrovascular Disease

  • Chapter
Taylor’s Cardiovascular Diseases

  • 603 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998;29:415–21.

    PubMed  CAS  Google Scholar 

  2. Brain attack statistics, 2000. Available at www.stroke.org.

    Google Scholar 

  3. Di Carlo A. Frequency of stroke in Europe: a collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Lon-gitudinal Study on Aging. Neurology 2000;54(11 suppl 5):S28–33.

    PubMed  Google Scholar 

  4. Albers GW, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 1998;114:683S–98S.

    PubMed  CAS  Google Scholar 

  5. Stroke risk factors and their impact, 2000. Available at www.stroke.org.

    Google Scholar 

  6. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993;269:232–6.

    Article  PubMed  CAS  Google Scholar 

  7. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995;274:155–60.

    Article  PubMed  CAS  Google Scholar 

  8. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. JAMA 1997;278:313–21.

    Article  PubMed  CAS  Google Scholar 

  9. Garber AJ. Attenuating cardiovascular risk factors in patients with type 2 diabetes. Am Fam Physician 2000;62:2633–42.

    PubMed  CAS  Google Scholar 

  10. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703–13.

    Google Scholar 

  11. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomized trials of antiplatelet therapy—1: prevention of death, myocardial infarction, and stroke by prolonged anti-platelet therapy in various categories of patients. BMJ 1994;308:81–106.

    Google Scholar 

  12. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–39.

    Google Scholar 

  13. Diener HC Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1–13.

    Article  PubMed  CAS  Google Scholar 

  14. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273;1421–8.

    Google Scholar 

  15. Cebul RD. Indications, outcomes, and provider volumes for carotid endarterectomy. JAMA 1998;279:1282–7.

    Article  PubMed  CAS  Google Scholar 

  16. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413–46.

    Google Scholar 

  17. MacMahon S, Rodgers A. Primary and secondary prevention of stroke. Clin Exp Hypertens 1996;18:537–46.

    PubMed  CAS  Google Scholar 

  18. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757–64.

    PubMed  CAS  Google Scholar 

  19. Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997;336:251–7.

    Article  PubMed  CAS  Google Scholar 

  20. Hankey GJ. Non-valvular atrial fibrillation and stroke prevention. National Blood Pressure Advisory Committee of the National Heart Foundation. Med J Aust 2001;174:234–9.

    PubMed  CAS  Google Scholar 

  21. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449–57.

    Google Scholar 

  22. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial fibrillation III randomized clinical trial. Lancet 1996;348:633–8.

    Google Scholar 

  23. Singer DE, Go AS. Antithrombotic therapy in atrial fibrillation. Clin Geriatr Med 2001;17:131–47.

    Article  PubMed  CAS  Google Scholar 

  24. Brown RD, Petty GW, O’Fallon WM, Wiebers DO, Whisnant JP. Incidence of transient ischemic attack in Rochester, Minnesota, 1985–1989. Stroke 1998;29:2109–13.

    PubMed  Google Scholar 

  25. Hankey GJ, Warlow CP. Symptomatic carotid ischaemic events: safest and most cost effective way of selecting patients for angiography, before carotid endarterectomy. BMJ 1990;300:1485–91.

    PubMed  CAS  Google Scholar 

  26. European Carotid Surgery Trialists’ Collaborative Group. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379–87.

    Google Scholar 

  27. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N. Engl J Med 1998;339:1415–25.

    PubMed  CAS  Google Scholar 

  28. Pancioli AM, Broderick J, Kothari R, et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 1998;279:1288–92.

    Article  PubMed  CAS  Google Scholar 

  29. Reith J, Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996;347:422–5.

    Article  PubMed  CAS  Google Scholar 

  30. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–7.

    Google Scholar 

  31. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999;340:1781–7.

    Article  PubMed  CAS  Google Scholar 

  32. Stroke the first hours: Guidelines for Acute Treatment, 2000. Available at www.stroke.org.

    Google Scholar 

  33. Schriger DL, Kalafut M, Starkman S, Krueger M, Saver JL. Cranial computed tomography interpretation in acute stroke. JAMA 1998;279:1293–7.

    Article  PubMed  CAS  Google Scholar 

  34. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The Atlantis Study: a randomized controlled trial. JAMA 1999;282:2019–26.

    Article  PubMed  CAS  Google Scholar 

  35. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT 11 study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003–11.

    Article  PubMed  CAS  Google Scholar 

  36. Young GR, Humphrey PR, Shaw MD, Nixon TE, Smith ET. Comparison of magnetic resonance angiography, duplex ultrasound, and digital subtraction angiography in assessment extracranial internal carotid stenosis. J Neurol Neurosurg Psychiatry 1994;57:166–78.

    Google Scholar 

  37. Shrier DA, Tanaka H, Numaguchi Y, Konno S, Patel U, Shibata D. CT angiography in the evaluation of acute stroke. AJNR 1997;18:1021–3.

    Google Scholar 

  38. Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (Toast) Investigators. Low molecular weight heparinoid, ORG 10172 (Danaparoid), and outcome after acute ischemic stroke. JAMA 1998;279:1265–72.

    Google Scholar 

  39. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569–81.

    Google Scholar 

  40. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641–9.

    Google Scholar 

  41. Taylor DW. Low-dose and high-dose acetylsalicylic acid for patients undergoing endarterectomy: a randomized controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet 1999;353:2179–84.

    PubMed  CAS  Google Scholar 

  42. Popovic EA, Danks RA, Siu KH. Experience with nimodipine in aneurysmal subarachnoid haemorrhage. Med J Aust 1993;158:91–3.

    PubMed  CAS  Google Scholar 

  43. Juvela S, Heiskanen O, Poranen A, Valtonen S, Kuurne T, Kaste M. The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg 1989;70:755–8.

    PubMed  CAS  Google Scholar 

  44. Heros RC. Surgical treatment of cerebellar infarction. Stroke 1992;23:937–8.

    PubMed  CAS  Google Scholar 

  45. Douglas MA, Haerer AF. Long-term prognosis of hypertensive intracerebral hemorrhage. Stroke 1982;13:488–91.

    PubMed  CAS  Google Scholar 

  46. Hill MD, Silver FL, Austin PC, Tu JV. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke 2000;31:123–7.

    PubMed  CAS  Google Scholar 

  47. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology 1997;49:1541–5.

    PubMed  CAS  Google Scholar 

  48. Brunnstrom S: Movement therapy in hemiplegia. New York: Harper & Row, 1970.

    Google Scholar 

  49. O’Sullivan S. Stroke. In: O’Sullivan S, Schmitz TJ, eds. Physical rehab assessment and treatment. Philadelphia: FA Davis, 1994;327–59.

    Google Scholar 

  50. Clinical Practice Guideline Number 16: post-stroke rehabilitation. AHCPR publication no. 95-0662. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, May 1995.

    Google Scholar 

Download references

Authors
  1. Michael H. Bross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David C. Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Family Medicine, Oregon Health & Science University School of Medicine, Portland, OR, 97201-3098, USA

    Robert B. Taylor M.D. (Professor Emeritus) & Scott A. Fields M.D. (Professor and Vice Chairman) (Professor Emeritus) &  (Professor and Vice Chairman)

  2. Department of Family and Community Medicine, Medical College of Wisconsin, Milwaukee, WI, 53226-0509, USA

    Alan K. David M.D. (Professor and Chairman) (Professor and Chairman)

  3. Department of Family Medicine, University of Mississippi School of Medicine, Jackson, MS, 39216-4500, USA

    D. Melessa Phillips M.D. (Professor and Chairman) (Professor and Chairman)

  4. Department of Family and Preventive Medicine, University of California, San Diego School of Medicine, San Diego, CA, 92103-0801

    Joseph E. Scherger M.D., M.P.H. (Clinical Professor) (Clinical Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Bross, M.H., Campbell, D.C. (2005). Cerebrovascular Disease. In: Taylor, R.B., David, A.K., Phillips, D.M., Fields, S.A., Scherger, J.E. (eds) Taylor’s Cardiovascular Diseases. Springer, New York, NY. https://doi.org/10.1007/0-387-27276-3_8

Download citation

  • DOI: https://doi.org/10.1007/0-387-27276-3_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22351-3

  • Online ISBN: 978-0-387-27276-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation